Company record
Nektar Therapeutics develops and manufactures biopharmaceuticals and innovative therapeutics targeting oncology, pain, anti‑infective, anti‑viral and immunology indications. Its portfolio comprises compounds, analgesics, small‑molecule drugs, peptides and biologic drug products.
This directory record does not yet have a linked material-flow brief.